Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Compound Enhances Skeletal Tissue Regeneration

By BiotechDaily International staff writers
Posted on 08 Apr 2013
New cutting-edge research revealed how a novel low-molecular-weight compound enhances ectopic bone formation and fracture repair.

The study, by investigators from conducted by the Atlanta Veterans Affairs Medical Center (GA, USA) and Emory University School of Medicine (Atlanta, GA, USA), was conducted to design and evaluate small molecules that could enhance recombinant human bone morphogenetic protein-2 (rhBMP-2) responsiveness. The investigation used two models to assess the ability of a small synthetic molecule to optimize bone formation in a rodent ectopic model and to determine whether an injection of that molecule accelerate callus formation in a rodent femoral fracture model.

The findings revealed that a single dose of the small molecule enhanced bone healing in the ectopic model combined with the occurrence of low-dose exogenous rhBMP-2, and in the femoral fracture model with the presence of only naturally occurring BMPs. The study’s findings, published in March 6, 2013, in the Journal of Bone and Joint Surgery.

SkelRegen, LLC (West Chester, PA, USA) is the first company to focus on newly identified small molecules that target different aspects of the skeletal tissue formation pathway. The study’s findings serves as additional confirmation that by following established procedures, SkelRegen continues to work on research to regenerate bone from scratch. “While our work on skeletal tissue regeneration is far from complete, this study exemplifies that research is continuing and SkelRegen technology is at the forefront,” said Stephen LaNeve, SkelRegen’s cofounder and CEO. “Our partnership with Emory University makes it possible for us to be part of such revolutionary work.”

Boden, SkelRegen’s cofounder and chief medical, science and technology officer, said, “The process was long and arduous and would not have been possible without the computational design work of the Emory/VA team led by Sree Sangadala, PhD But, ultimately these results further demonstrate how bone regeneration with small molecules will transform musculoskeletal care.”

SkelRegen identified not one, but multiple small molecules that are osteoinductive and target different features of the skeletal tissue formation pathway. All of the compounds are inexpensive to manufacture and many of the compounds are clear for other uses by the US Food and Drug Administration (FDA), therefore, they already have acceptable safety and toxicity profiles.

Related Links:

Atlanta Veterans Affairs Medical Center
Emory University School of Medicine
Regen



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Differences in the structure of a small lung artery (top row) and heart cross section (lower row) of rodents without disease (far left column); with pulmonary hypertension (middle) and a diseased rodent treated with the HDL peptide (right). Note the much narrowed lung artery, and thick walls and larger chamber of the heart in the diseased animal and improvements with 4F peptide treatment (Photo courtesy of UCLA - University of California, Los Angeles).

Apolipoprotein A-1 Mimetic Peptide Reverses Pulmonary Hypertension in Rodent Models

A small peptide that mimics the activity of apolipoprotein A-1 (apo A-1), the main protein component of the high density lipoproteins (HDL), counteracted the effects of oxidized lipids and alleviated symptoms... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel
Image: Leica Microsystems launches the inverted research microscope platform Leica DMi8 (Photo courtesy of Leica Microsystems).

New Inverted Microscope Designed to Readily Adapt to Changing Research Demands

A new inverted microscope for biotech and other life science laboratories was designed to readily accommodate modifications and upgrades to allow it to keep current with changing research demands and interests.... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.